Unlock instant, AI-driven research and patent intelligence for your innovation.
Pharmaceutical composition for treating heart cerebrovascular disease
What is Al technical title?
Al technical title is built by PatSnap Al team. It summarizes the technical point description of the patent document.
A technology of cardiovascular and cerebrovascular diseases and compositions, which is applied in the direction of cardiovascular system diseases, drug combinations, active ingredients of hydroxyl compounds, etc., and can solve problems such as refractory treatment, chemical drug withdrawal recurrence, toxic and side effects, etc.
Active Publication Date: 2012-01-04
JILIN ZIXIN PHARMA
View PDF0 Cites 0 Cited by
Summary
Abstract
Description
Claims
Application Information
AI Technical Summary
This helps you quickly interpret patents by identifying the three key elements:
Problems solved by technology
Method used
Benefits of technology
Problems solved by technology
[0003] At present, many chemical drugs are used in the treatment of the above-mentioned cardiovascular and cerebrovascular diseases, but they are difficult to treat due to problems such as drug withdrawal, recurrence and toxic side effects. The ideal drug for the treatment of the above diseases has yet to be developed
Method used
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more
Image
Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
Click on the blue label to locate the original text in one second.
Reading with bidirectional positioning of images and text.
Smart Image
Examples
Experimental program
Comparison scheme
Effect test
Embodiment 1
[0065] The preparation of embodiment 1 capsule of the present invention
[0066] 50g total flavonoids of Caulis Spatholobus, 30g total glucosides of paeony, 40g turmeric sesquiterpenes, 60g tangerine peel essential oil, 50g ethanol extract of medlar, 60g water extract of Radix Ophiopogon japonicus, 10g amygdalin, 30g safflower water extract, Panax notoginseng total saponins 50g, woody essential oil 20g, sealwort alcohol extract 150g, borneol 5g, salvia miltiorrhiza 60g alcohol extract, balm essential oil 30g, chuanxiong ferulic acid 20g, calamus essential oil 40g, ginseng total saponins 20g.
[0067] Add conventional auxiliary materials for preparing capsules, granulate and pack into capsules.
[0068] The above-mentioned various extracts in the present invention can be obtained by any extraction method in the prior art. Preferably:
[0069] Total flavonoids of Caulis Spatholobus: Weigh an appropriate amount of raw materials, extract with 50%-90% ethanol under reflux for 1-3...
Embodiment 2
[0085] The preparation of embodiment 2 tablet of the present invention
[0086] Total flavonoids of Caulis Spatholobus 100g, total glucosides of paeony 65g, turmeric sesquiterpenes 95g, tangerine peel essential oil 105g, wolfberry alcoholic extract 100g, Ophiopogon japonicus water extract 130g, amygdalin 30g, safflower water extract 65g, Panax notoginseng total saponins 100g, woody essential oil 60g, sealwort alcohol extract 225g, borneol 27.5g, salvia miltiorrhiza 130g alcohol extract, balm essential oil 90g, chuanxiong ferulic acid 60g, calamus essential oil 70g, total ginsenosides 60g.
[0087] Add 4487.5 g of conventional adjuvants for tablet preparation to make 20000 tablets, each weighing 0.3 g.
Embodiment 3
[0088] The preparation of embodiment 3 granules of the present invention
[0089] 150g of total flavonoids of Gallis Spatholobus, 100g of total glucosides of paeony, 150g of turmeric sesquiterpenes, 150g of tangerine peel essential oil, 150g of wolfberry alcoholic extract, 200g of Radix Ophiopogon japonicus water extract, 50g of amygdalin, 100g of safflower water extract, Panax notoginseng total saponins 150g, woody essential oil 100g, sealwort alcohol extract 300g, borneol 50g, salvia miltiorrhiza 200g alcohol extract, balm essential oil 150g, chuanxiong ferulic acid 100g, calamus essential oil 100g, total ginsenosides 100g.
[0090] Add conventional excipients for tablet preparation to make granules.
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More
PUM
Login to View More
Abstract
The invention relates to a pharmaceutical composition for treating heart cerebrovascular disease, belonging to a traditional Chinese medicine composition. The pharmaceutical composition contains active substances based on the parts by weight: 5-15 parts of spatholobus suberectus total flavanone, 3-10 parts of radix paeoniae rubra total glycoside, 4-15 parts of radix curcumae sesquiterpene, 6-15 parts of tangerine peelessential oil, 5-15 parts of barbary wolfberry fruit alcohol extract, 6-20 parts of dwarf lilyturf root water extract, 1-5 parts of amygdalin, 3-10 parts of safflower water extract, 5-15 parts of panax notoginsengsaponin, 2-10 parts of costustoot essential oil, 15-30 parts of rhizoma polygonati alcohol extract, 0.5-5 parts of borneol, 6-20 parts of salvia miltiorrhiza alcohol extract, 3-15 parts of rosewood heart wood essential oil, 2-10 parts of ligusticum wallichii ferulic acid, 4-10 parts of rhizoma acori graminei essential oil and 2-10 parts of ginseng total saponin. The pharmaceutical composition is used for treating angina caused by coronary sclerosis and diseases such as chest distress and shortness of breath, insufficient heart-qi, blood stasis pain, etc.
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More
Application Information
Patent Timeline
Application Date:The date an application was filed.
Publication Date:The date a patent or application was officially published.
First Publication Date:The earliest publication date of a patent with the same application number.
Issue Date:Publication date of the patent grant document.
PCT Entry Date:The Entry date of PCT National Phase.
Estimated Expiry Date:The statutory expiry date of a patent right according to the Patent Law, and it is the longest term of protection that the patent right can achieve without the termination of the patent right due to other reasons(Term extension factor has been taken into account ).
Invalid Date:Actual expiry date is based on effective date or publication date of legal transaction data of invalid patent.
Login to View More 
Login to View More